Dr Reddys Dividends
| RDY Stock | USD 13.99 0.31 2.17% |
Dividends Paid is likely to rise to about 7 B in 2024, whereas Dividend Yield is likely to drop 0.03 in 2024. Dr Reddys' past performance could be the main factor of why investors trade Dr Reddys Laboratories stock today. Investors should clearly understand every aspect of the Dr Reddys dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Dr Reddys' dividend schedule and payout information. Dr Reddys Laboratories dividends can also provide a clue to the current valuation of Dr Reddys.
Number Of Dividends | Years Issued 24 | Previous Year 2 Times | Current Year 2 Times | Year Average 1.21 | Volatility 0.41 |
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 6.6 B | 7 B | |
| Dividend Yield | 0.03 | 0.03 | |
| Dividend Payout Ratio | 0.12 | 0.11 | |
| Dividend Paid And Capex Coverage Ratio | 1.33 | 1.28 |
RDY |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Dr Reddys must own a stock before its ex-dividend date to receive its next dividend.
Dr Reddys Dividends Paid Over Time
Today, most investors in Dr Reddys Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dr Reddys' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Dr Reddys dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Dr Reddys Historical Dividend Yield Growth
A solid dividend growth pattern of Dr Reddys could indicate future dividend growth is likely, which can signal long-term profitability for Dr Reddys Laboratories. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Dr Reddys Laboratories dividend as a percentage of Dr Reddys stock price. Dr Reddys Laboratories dividend yield is a measure of Dr Reddys stock productivity, which can be interpreted as interest rate earned on an Dr Reddys investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Dr Reddys Expected Dividend Income Per Share
Dividend payment represents part of Dr Reddys' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Dr Reddys. Dr Reddys' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.31 Bottom Scenario | $0.32 | $0.33 Top Scenario |
One Year
Dr Reddys Laboratories expected dividend income per share adjusted for ongoing price standard deviation
Dr Reddys Past Distributions to stockholders
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.15) | Dividend Share 8 | Earnings Share 0.79 | Revenue Per Share 60.1437 | Quarterly Revenue Growth 0.165 |
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.